Reporter May 22 2015

May 21, 2015

Study to explore optimal daily aspirin dose for heart health

The Vanderbilt-based Mid-South Clinical Data Research Network (CDRN) is among seven CDRNs that will collaboratively mount a three-year, $14 million randomized clinical trial to determine the best daily dose of aspirin for preventing heart attacks and strokes among people living with heart disease.

By Paul Govern